![]() |
|
|
Vol. 296, Issue 3, 857-868, March 2001
Department of Psychiatry, The Psychiatric Institute, University of
Illinois at Chicago, Chicago, Illinois (S.C.P., A.R., N.M.); and
Veterans Affairs Chicago Health Care System (West Side Division),
Chicago, Illinois (S.C.P., A.R., N.M.)
This investigation examined the effects of chronic ethanol treatment
(15 days) and its withdrawal (24 h) on the expression and
phosphorylation of cyclic AMP-response element-binding (CREB) protein
in the rat cortex. The effects of chronic ethanol treatment and
withdrawal on protein kinase A (PKA) activity and on the expression of
the regulatory RII-
- and the
-subtype catalytic subunits of PKA,
and on the protein expression of Ca2+/calmodulin-dependent
protein kinase IV (CaM kinase IV) and calcineurin in the rat cortex
were also investigated. It was found that ethanol withdrawal but not
ethanol treatment produced a significant decrease in the phosphorylated
CREB (p-CREB) and CaM kinase IV protein levels in the frontal,
parietal, and piriform cortex. Ethanol treatment and its withdrawal had
no effect on the protein levels of total CREB in the frontal, parietal,
and piriform cortex. On the other hand, ethanol treatment produced a
significant reduction in the protein levels of CREB, p-CREB, and CaM
kinase IV in the cingulate gyrus, and these changes reverted to normal
levels during ethanol withdrawal. Total CREB protein levels were
significantly higher in the cingulate gyrus during ethanol withdrawal.
It was also observed that mRNA levels of CREB were significantly higher in the rat cortex during ethanol withdrawal but not during ethanol treatment. The protein levels of RII-
- and
-subtype catalytic subunits of PKA and PKA activity were not modified in the rat cortex by
chronic ethanol treatment and its withdrawal. Furthermore, the
expression of calcineurin in the rat cortex was not altered during
ethanol treatment and withdrawal. Taken together, these results suggest
the possibility that decreased CREB-dependent events in the
neurocircuitry of the frontal, parietal, and piriform cortex may play
an important role in the phenomenon of alcohol dependence and also that
decreased CREB-dependent events in the neurocircuitry of the cingulate
gyrus may play a role in alcohol tolerance.
This article has been cited by other articles:
![]() |
C. C.Y Wong and G. Schumann Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders Phil Trans R Soc B, October 12, 2008; 363(1507): 3213 - 3222. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schumann, M. Johann, J. Frank, U. Preuss, N. Dahmen, M. Laucht, M. Rietschel, D. Rujescu, A. Lourdusamy, T.-K. Clarke, et al. Systematic Analysis of Glutamatergic Neurotransmission Genes in Alcohol Dependence and Adolescent Risky Drinking Behavior Arch Gen Psychiatry, July 1, 2008; 65(7): 826 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pandey, R. Ugale, H. Zhang, L. Tang, and A. Prakash Brain Chromatin Remodeling: A Novel Mechanism of Alcoholism J. Neurosci., April 2, 2008; 28(14): 3729 - 3737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pandey, H. Zhang, R. Ugale, A. Prakash, T. Xu, and K. Misra Effector Immediate-Early Gene Arc in the Amygdala Plays a Critical Role in Alcoholism J. Neurosci., March 5, 2008; 28(10): 2589 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Acheampong, Z. Parveen, A. Mengistu, N. Ngoubilly, B. Wigdahl, A. S. Lossinsky, R. J. Pomerantz, and M. Mukhtar Cholesterol-Depleting Statin Drugs Protect Postmitotically Differentiated Human Neurons against Ethanol- and Human Immunodeficiency Virus Type 1-Induced Oxidative Stress In Vitro J. Virol., February 1, 2007; 81(3): 1492 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pandey, H. Zhang, A. Roy, and K. Misra Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. J. Neurosci., August 9, 2006; 26(32): 8320 - 8331. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. S. Rani, M. Qiang, and M. K. Ticku Potential Role of cAMP Response Element-Binding Protein in Ethanol-Induced N-Methyl-D-aspartate Receptor 2B Subunit Gene Transcription in Fetal Mouse Cortical Cells Mol. Pharmacol., June 1, 2005; 67(6): 2126 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Medina, T. E. Krahe, and A. S. Ramoa Early Alcohol Exposure Induces Persistent Alteration of Cortical Columnar Organization and Reduced Orientation Selectivity in the Visual Cortex J Neurophysiol, March 1, 2005; 93(3): 1317 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Jung, M. B. Gatch, and J. W. Simpkins Estrogen Neuroprotection Against the Neurotoxic Effects of Ethanol Withdrawal: Potential Mechanisms Experimental Biology and Medicine, January 1, 2005; 230(1): 8 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nixon and F. T. Crews Temporally Specific Burst in Cell Proliferation Increases Hippocampal Neurogenesis in Protracted Abstinence from Alcohol J. Neurosci., October 27, 2004; 24(43): 9714 - 9722. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pandey, A. Roy, H. Zhang, and T. Xu Partial Deletion of the cAMP Response Element-Binding Protein Gene Promotes Alcohol-Drinking Behaviors J. Neurosci., May 26, 2004; 24(21): 5022 - 5030. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Medina, T. E. Krahe, D. M. Coppola, and A. S. Ramoa Neonatal Alcohol Exposure Induces Long-Lasting Impairment of Visual Cortical Plasticity in Ferrets J. Neurosci., November 5, 2003; 23(31): 10002 - 10012. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roy, N. Mittal, H. Zhang, and S. C. Pandey Modulation of Cellular Expression of Glucocorticoid Receptor and Glucocorticoid Response Element-DNA Binding in Rat Brain during Alcohol Drinking and Withdrawal J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 774 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Asher, T. D. Cunningham, L. Yao, A. S. Gordon, and I. Diamond Ethanol Stimulates cAMP-Responsive Element (CRE)-Mediated Transcription via CRE-Binding Protein and cAMP-Dependent Protein Kinase J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 66 - 70. [Abstract] [Full Text] [PDF] |
||||